New pill joins fight against deadly brain cancer
Disease control
Not yet recruiting
This trial is testing if adding a new oral medication called NG101m to the standard treatment helps people with newly diagnosed glioblastoma live longer. About 52 adults will take NG101m capsules along with their usual chemotherapy and radiation. The main goal is to see if this c…
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC